Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial
about
Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and CancerOral retinoids and rexinoids in cutaneous T-cell lymphomasCost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspective.Hand eczemaVitamin effects on the immune system: vitamins A and D take centre stage.Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.Update on the use of alitretinoin in treating chronic hand eczema.Management of chronic hand eczema.Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cellsRetinoids in the treatment of skin aging: an overview of clinical efficacy and safetyEfficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.Use of Longitudinal Dose-Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE).Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema.Alitretinoin in Dermatology-An Update.Efficacy and Safety of Alitretinoin for Chronic Hand Eczema in Korean Patients.Canadian hand dermatitis management guidelines.Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.Guidelines for diagnosis, prevention and treatment of hand eczema--short version.Guidelines for diagnosis, prevention and treatment of hand eczema.Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.Oral alitretinoin for the treatment of recalcitrant pityriasis rubra pilaris.Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin.Alitretinoin--its use in intractable hand eczema and other potential indications.Possible benefit of oral alitretinoin in T-lymphoproliferative diseases: a report of two patients with palmoplantar hyperkeratotic-rhagadiform skin changes and mycosis fungoides or Sézary syndrome.Treatment of Darier disease with oral alitretinoin.An Update on the Use of Alitretinoin for Chronic Hand Dermatitis in a Dermatology Practice Setting.Drug survival of cyclosporine in the treatment of hand eczema: a multicentre, daily use study.Treatment of cutaneous T-cell lymphoma with oral alitretinoin.Low levels of alitretinoin in seminal fluids after repeated oral doses in healthy men.Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study.The effectiveness of alitretinoin for the treatment of chronic hand eczema: A meta-analysis.
P2860
Q26800202-BEB3EB78-C517-4B94-8A44-D4E110627104Q26992062-AF074BAD-A738-4FD2-AD42-4B587A010958Q33616841-74EA3CC9-A5F6-496E-9297-6D66A1304437Q33683475-37F62E01-E795-4C04-9926-3AC93B9E4B70Q34005584-5F6DCCCE-DFEB-42B6-8398-CE0B30F76F45Q34345596-42DD339C-8675-456B-84FF-47BCC2D0D196Q34620382-63912230-68C5-43FE-BA39-704F1A69B124Q34687460-A4E7CBA5-B583-4EBA-AC01-B7DFCE5F6E24Q34707563-BD4BDAE1-F77D-4DE5-A71E-BE35538D94F1Q34719686-0D7DDC25-9634-4C86-B8D0-9BE5A2EBF577Q34753923-D5827E96-58D0-4A68-A0E7-9F1AC28CC06CQ35599953-A1A6C72F-DCE0-44A0-9B5A-EA6E23C717F5Q35936420-E8DBCBFD-523B-4D30-82C9-BBE79F471686Q36147795-F78657CD-5126-44CC-816B-63126C58CEABQ36946020-62FAECE8-AD46-439B-BAC8-963CB114CADDQ37810349-60272A74-9C09-413B-BE8C-DE3FF29C67FDQ38040124-969D187D-049D-4D33-ABA3-8A74D6512619Q38339846-4F1F4A3E-4417-4448-92A7-AB4169792CFAQ38374914-C0BC2FE8-A4A4-489C-B81C-DEB01483A7E1Q41053834-544E6D0E-F8E3-48C9-AED4-D12C592899DEQ42000521-65DE4254-8B5E-42A6-AFF0-149381109F53Q42058866-8AD35756-546B-426C-9592-EEE9B8F73E64Q42595956-7A72C621-AFA0-4269-AE9D-5E9F43A7C8A1Q43270269-D11720A1-23FD-46D6-AA22-7A4FBEA62177Q43501959-6C93D97A-A84D-4BAA-8D0E-24C25AE3348CQ50139943-42BBC030-8AAF-4FF2-B070-3CBD10BD8EE9Q50581922-F8D98F45-8844-47F4-8D30-7DC13246066FQ51316502-81039DD3-AE54-4E20-BAF2-D9E0F6072E0EQ51483611-E0C30261-0481-4878-8BDC-5D6DEE525230Q53303560-EA1F33B3-FDB9-4F84-BA78-A8755B0EF597Q55396120-B887D342-8B5F-47DB-81A1-CE777B9180E8
P2860
Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@ast
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@en
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@nl
type
label
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@ast
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@en
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@nl
prefLabel
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@ast
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@en
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@nl
P2093
P3181
P1433
P1476
Oral alitretinoin (9-cis-retin ...... -controlled, multicenter trial
@en
P2093
Attila Horváth
Christos C Zouboulis
Dorota Galewicz
Frederik Grønhøj Larsen
Jean Paul Ortonne
Kristian Thestrup-Pedersen
Martin Harsch
Maurice Zultak
Peter Jan Coenraads
Thomas C Brown
P304
P3181
P356
10.1001/ARCHDERM.140.12.1453
P407
P577
2004-12-01T00:00:00Z